{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T21:07:51Z","timestamp":1794517671350,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":40,"publisher":"Springer New York","isbn-type":[{"value":"9781493936595","type":"print"},{"value":"9781493936618","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3661-8_1","type":"book-chapter","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T06:04:12Z","timestamp":1462428252000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetically Defined Strains in Drug Development and Toxicity Testing"],"prefix":"10.1007","author":[{"given":"Michael F. W.","family":"Festing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley CG, Ellis LM (2012) Drug development: raise standards for preclinical cancer research. Nature 483:531\u2013533","journal-title":"Nature"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrd3439-c1","volume":"10","author":"F Prinz","year":"2011","unstructured":"Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17482960701856300","volume":"9","author":"S Scott","year":"2008","unstructured":"Scott S, Kranz JE, Cole J et al (2008) Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 9:4\u201315","journal-title":"Amyotroph Lateral Scler"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"e1002165","DOI":"10.1371\/journal.pbio.1002165","volume":"13","author":"LP Freedman","year":"2015","unstructured":"Freedman LP, Cockburn IM, Simcoe TS (2015) The economics of reproducibility in preclinical research. PLoS Biol 13:e1002165","journal-title":"PLoS Biol"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/521274a","volume":"521","author":"M Baker","year":"2015","unstructured":"Baker M (2015) Reproducibility crisis: blame it on the antibodies. Nature 521:274\u2013276","journal-title":"Nature"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/505612a","volume":"505","author":"FS Collins","year":"2014","unstructured":"Collins FS, Tabak LA (2014) Policy: NIH plans to enhance reproducibility. Nature 505:612\u2013613","journal-title":"Nature"},{"key":"1_CR7","unstructured":"Food and Drug Administration (2004) Challenge and opportunity on the critical path to new medical products. [electronic article]. \n                  http:\/\/www.fda.gov\/oc\/initiatives\/criticalpath\/whitepaper html."},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1568026013394949","volume":"1","author":"GW Caldwell","year":"2001","unstructured":"Caldwell GW, Ritchie DM, Masucci JA et al (2001) The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. Curr Top Med Chem 1:353\u2013366","journal-title":"Curr Top Med Chem"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ilar\/ilu047","volume":"55","author":"JP Garner","year":"2014","unstructured":"Garner JP (2014) The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it? ILAR J 55:438\u2013456","journal-title":"ILAR J"},{"key":"1_CR10","unstructured":"Innovative Medicines Initiative (2008) The innovative medicines initiative. \n                  http:\/\/www.imi.europa.eu\/"},{"key":"1_CR11","volume-title":"The principles of humane experimental technique","author":"WMS Russell","year":"1959","unstructured":"Russell WMS, Burch RL (1959) The principles of humane experimental technique. Universities Federation for Animal Welfare, Potters Bar, England, Special Edition"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0192623310373776","volume":"38","author":"MF Festing","year":"2010","unstructured":"Festing MF (2010) Inbred strains should replace outbred stocks in toxicology, safety testing, and drug development. Toxicol Pathol 38:681\u2013690","journal-title":"Toxicol Pathol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0015-6264(75)80302-6","volume":"13","author":"MFW Festing","year":"1975","unstructured":"Festing MFW (1975) A case for using inbred strains of laboratory animals in evaluating the safety of drugs. Food Cosmet Toxicol 13:369\u2013375","journal-title":"Food Cosmet Toxicol"},{"key":"1_CR14","first-page":"117","volume":"75","author":"MFW Festing","year":"1980","unstructured":"Festing MFW (1980) The choice of animals in toxicological screening: inbred strains and the factorial design of experiment. Acta Zool Pathol Antverp 75:117\u2013131","journal-title":"Acta Zool Pathol Antverp"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-642-71248-7_15","volume":"9","author":"MFW Festing","year":"1986","unstructured":"Festing MFW (1986) The case for isogenic strains in toxicological screening. Arch Toxicol Suppl 9:127\u2013137","journal-title":"Arch Toxicol Suppl"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408448709089855","volume":"18","author":"MFW Festing","year":"1987","unstructured":"Festing MFW (1987) Genetic factors in toxicology: implications for toxicological screening. CRC Crit Rev Toxicol 18:1\u201326","journal-title":"CRC Crit Rev Toxicol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0041-008X(90)90020-U","volume":"102","author":"MFW Festing","year":"1990","unstructured":"Festing MFW (1990) Contemporary issues in toxicology: use of genetically heterogeneous rats and mice in toxicological research: a personal perspective. Toxicol Appl Pharmacol 102:197\u2013204","journal-title":"Toxicol Appl Pharmacol"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/ilar\/ilu036","volume":"55","author":"MF Festing","year":"2014","unstructured":"Festing MF (2014) Evidence should trump intuition by preferring inbred strains to outbred stocks in preclinical research. ILAR J 55:399\u2013404","journal-title":"ILAR J"},{"key":"1_CR19","unstructured":"Committee on Toxicity (2007) Variability and uncertainty in toxicology of chemicals in food, consumer products and the environment. COT, London, Food Standards Agency"},{"issue":"3","key":"1_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/mutage\/9.3.179","volume":"9","author":"J Ashby","year":"1994","unstructured":"Ashby J, Tinwell H (1994) Use of transgenic mouse lacI\/Z mutation assays in genetic toxicology. Mutagenesis 9(3):179\u2013181","journal-title":"Mutagenesis"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/01926230252824860","volume":"30","author":"E Floyd","year":"2002","unstructured":"Floyd E, Mann P, Long G et al (2002) The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists. Toxicol Pathol 30:147\u2013156","journal-title":"Toxicol Pathol"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/ng1105-1155","volume":"37","author":"SD Brown","year":"2005","unstructured":"Brown SD, Chambon P, de Angelis MH (2005) EMPReSS: standardized phenotype screens for functional annotation of the mouse genome. Nat Genet 37:1155","journal-title":"Nat Genet"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2967\/jnumed.108.055442","volume":"49","author":"BL Franc","year":"2008","unstructured":"Franc BL, Acton PD, Mari C et al (2008) Small-animal SPECT and SPECT\/CT: important tools for preclinical investigation. J Nucl Med 49:1651\u20131663","journal-title":"J Nucl Med"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrd1377","volume":"3","author":"S Petit-Zeman","year":"2004","unstructured":"Petit-Zeman S (2004) Rat genome sequence reignites preclinical model debate. Nat Rev Drug Discov 3:287\u2013288","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ng1665","volume":"37","author":"R Chia","year":"2005","unstructured":"Chia R, Achilli F, Festing MF et al (2005) The origins and uses of mouse outbred stocks. Nat Genet 37:1181\u20131186","journal-title":"Nat Genet"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"e1001085","DOI":"10.1371\/journal.pgen.1001085","volume":"6","author":"B Yalcin","year":"2010","unstructured":"Yalcin B, Nicod J, Bhomra A et al (2010) Commercially available outbred mice for genome-wide association studies. PLoS Genet 6:e1001085","journal-title":"PLoS Genet"},{"issue":"3","key":"1_CR27","doi-asserted-by":"publisher","first-page":"e4729","DOI":"10.1371\/journal.pone.0004729","volume":"4","author":"KA Aldinger","year":"2009","unstructured":"Aldinger KA, Sokoloff G, Rosenberg DM et al (2009) Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One 4(3):e4729","journal-title":"PLoS One"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-074901-0.50008-3","volume-title":"The laboratory rat","author":"JR Lindsey","year":"1979","unstructured":"Lindsey JR (1979) Historical Foundatins. In: Baker HJ, Lindsey JR, Weisbroth SH (eds) The laboratory rat. Academic, New York, pp 1\u201336"},{"key":"1_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-03816-9","volume-title":"Inbred strains in biomedical research","author":"MFW Festing","year":"1979","unstructured":"Festing MFW (1979) Inbred strains in biomedical research. Macmillan Press, London, Basingstoke"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tig.2006.09.010","volume":"22","author":"RA Taft","year":"2006","unstructured":"Taft RA, Davisson M, Wiles MV (2006) Know thy mouse. Trends Genet 22:649\u2013653","journal-title":"Trends Genet"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/263230a0","volume":"263","author":"MFW Festing","year":"1976","unstructured":"Festing MFW (1976) Phenotypic variability of inbred and outbred mice. Nature 263:230\u2013232","journal-title":"Nature"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2007.10.001","volume":"13","author":"JC Stevens","year":"2007","unstructured":"Stevens JC, Banks GT, Festing MF et al (2007) Quiet mutations in inbred strains of mice. Trends Mol Med 13:512\u2013519","journal-title":"Trends Mol Med"},{"key":"1_CR33","volume-title":"The design of experiments","author":"RA Fisher","year":"1960","unstructured":"Fisher RA (1960) The design of experiments. Hafner Publishing Company, Inc., New York"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/01926230600935938","volume":"34","author":"A King-Herbert","year":"2006","unstructured":"King-Herbert A, Thayer K (2006) NTP workshop: animal models for the NTP rodent cancer bioassay: stocks and strains--should we switch? Toxicol Pathol 34:802\u2013805","journal-title":"Toxicol Pathol"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/bdrb.21056","volume":"98","author":"K Pritchet","year":"2013","unstructured":"Pritchet K, Clifford CB, Festing MF (2013) The effects of shipping on early pregnancy in laboratory rats. Birth Defects Res B Dev Reprod Toxicol 98:200\u2013205","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/01926230500311222","volume":"33","author":"KP Keenan","year":"2005","unstructured":"Keenan KP, Hoe CM, Mixson L et al (2005) Diabesity: a polygenic model of dietary-induced obesity from ad libitum overfeeding of Sprague\u2013Dawley rats and its modulation by moderate and marked dietary restriction. Toxicol Pathol 33:650\u2013674","journal-title":"Toxicol Pathol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.reprotox.2007.06.004","volume":"24","author":"CA Richter","year":"2007","unstructured":"Richter CA, Birnbaum LS, Farabollini F et al (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199\u2013224","journal-title":"Reprod Toxicol"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/0192623313517771","volume":"42","author":"MF Festing","year":"2014","unstructured":"Festing MF (2014) Extending the statistical analysis and graphical presentation of toxicity test results using standardized effect sizes. Toxicol Pathol 42:1238\u20131249","journal-title":"Toxicol Pathol"},{"issue":"11","key":"1_CR39","doi-asserted-by":"publisher","first-page":"e112955","DOI":"10.1371\/journal.pone.0112955","volume":"9","author":"MF Festing","year":"2014","unstructured":"Festing MF (2014) The extended statistical analysis of toxicity tests using standardised effect sizes (SESs): a comparison of nine published papers. PLoS One 9(11):e112955","journal-title":"PLoS One"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0278-6915(00)00149-6","volume":"39","author":"MFW Festing","year":"2001","unstructured":"Festing MFW, Diamanti P, Turton JA (2001) Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food Chem Toxicol 39:375\u2013383","journal-title":"Food Chem Toxicol"}],"container-title":["Methods in Molecular Biology","Mouse Models for Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3661-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:02:15Z","timestamp":1559430135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3661-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493936595","9781493936618"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3661-8_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-3661-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"6 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}